Stock

Haemonetics Corporation HAE

$76.38+2.66%

All stocks Create account to unlock

Overview

HAE market data

Price History

HAE price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for HAE. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

8 captured

Global Apheresis Market to Reach USD 4.41 Billion by 2031, Driven by Plasma-Based Therapies and Automated Technologies · Jul 24, 2026, 3:15 PM

Mizuho Maintains Outperform on Haemonetics, Raises Price Target to $90 · Jul 15, 2026, 6:28 PM

BTIG Reiterates Buy on Haemonetics, Maintains $84 Price Target · Jun 26, 2026, 11:40 AM

Mizuho Maintains Outperform on Haemonetics, Raises Price Target to $85 · Jun 15, 2026, 5:35 PM

8-K filing — HAEMONETICS CORP (HAE) · Jun 5, 2026, 10:33 AM

Citigroup Maintains Neutral on Haemonetics, Raises Price Target to $70 · May 28, 2026, 8:02 PM

This Texas Instruments Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday · May 22, 2026, 1:15 PM

Barrington Research Maintains Outperform on Haemonetics, Lowers Price Target to $89 · May 12, 2026, 9:00 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock